Jazz Pharma's decision to revoke U.S. patent for rival narcolepsy drug

Published Date: 02 Mar 2023

A U.S. court on Friday ordered Jazz Pharmaceuticals to revoke its patents related to its flagship narcolepsy drug Xyrem from the FDA-approved brand name drug after winning a case against Avadel foe CNS Pharmaceuticals.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Inadvertent lung cancer screening results are discussed in a new study.

2.

Recent research suggests that vitamin supplements may increase the risk of developing cancer.

3.

Fake Cancer Drugs; Let's Talk About Sex; Reducing Cancer-Related Fatigue

4.

In a study, immune detection of oral cancers is linked to obesity.

5.

Video: How to treat kidney disease?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot